Evidence map›Paper›PMID 42667072›Full record

ArticleInternational journal of pharmaceutics: X2026

Unlocking the brain: Biodistribution insights into tween 80 nanoliposomes in healthy brains.

Masoud Khatibi, Seyedeh Maryam Hosseinikhah, Seyedeh Hoda Alavizdaeh, Fatemeh Gheybi, Mahmoud Reza Jaafari, Zohreh Efati, Farzaneh Afshari, Samaneh Yaghoubi, Parviz Norouzi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of pharmaceutics: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masoud KhatibiNanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Seyedeh Maryam HosseinikhahNanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Seyedeh Hoda AlavizdaehNanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Fatemeh GheybiNanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahmoud Reza JaafariNanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Zohreh EfatiStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Farzaneh AfshariDepartment of Pathology, Mashhad University of Medical Sciences, Mashhad, Iran.
Samaneh YaghoubiNanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Parviz NorouziCenter of Excellence in Electrochemistry, Collage of Science, University of Tehran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Limited drug penetration across the blood-brain barrier hinders brain tumor therapy. This study evaluated doxorubicin-loaded nanoliposomes with varying Tween 80 contents, investigating formulation characteristics, release profiles, cytotoxicity on cancer and healthy cells, and tissue distribution in healthy models. Nanoliposomes were prepared

Indexed as

Blood brain barrierDoxorubicinNanoliposomeTween 80

Identifiers

PMID42667072
PMCPMC13524492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.